Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in to save your work
Pre-market
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverLFCR
HealthcareNMSUSD

Lifecore Biomedical, Inc.

$00123456789.0012345678900123456789-2.3%
52w low (est.) $3.41$5.51 52w high (est.)
Market data · updated 1h ago
Market data
Market cap
USD175.92M
52w range
USD3.63 - USD8.98
Beta
1.06
Sector
Healthcare
Data quality
63/100
Valuation
PEG ratio
2.66
Quality & efficiency
Moat score
11/100
Profit margin
-23.8%
Debt / equity
7.23
Growth & analysts
Analyst target
USD6.83
Target upside
+57.8%
Analysts
3
Run the 10-point checklist before you buy How these numbers are made

About Lifecore Biomedical, Inc.

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

Valuation

ValueGrowthProfitHealthIncome13QUALITY
Overall Rating
27
Sell
Sell

Derived from filed metrics · Moderate confidence (63% of the inputs available)

Moat Score11
DCF Intrinsic Value
Not covered by our valuation model yet.

Moat, DCF and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
USD175.92M
P/E Ratio
N/A
Dividend Yield
0.00%
Revenue Growth
0.0%
Profit Margin
-23.8%
ROE
0.0%
Debt / Equity
7.23
Beta
1.06
Beaten Down
vs Healthcare sector:Moat 11 vs 7Yield 0.00% vs 0.3%

Statistics

Similar Stocks · Healthcare

LLY73
$920.00+0.7%
AZN.L72
£105.20+0.6%
UNH71
$492.10+1.6%
JNJ70
$146.20-0.2%

Latest News · LFCR